NATICK, Mass.–(BUSINESS WIRE)–Allurion Applied sciences, Inc. (“Allurion” or the “Firm”) (NYSE: ALUR), an organization devoted to ending weight problems, at present introduced its intention to provoke a scientific research on the mixture of the Allurion Program with GLP-1 agonists to enhance muscle mass and general physique composition. Earlier research in sufferers present process GLP-1 remedy have demonstrated reductions in lean mass of roughly 40% as a proportion of complete weight misplaced.1 In distinction, in earlier
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/allurion-announces-plans-to-optimize-muscle-mass-during-glp-1-therapy-in-combination-with-the-allurion-program/
